Bharat Parenterals Limited (BOM:541096)
1,803.40
-58.65 (-3.15%)
At close: Oct 16, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 12.43 billion as of October 16, 2026. It is the 23,253rd most valuable company in the world and the 1,484th biggest in India. Its market cap has increased by 46.20% in one year.
Market Cap
12.43B
Enterprise Value
13.61B
Revenue
3.23B
Global Rank
Country Rank
#1,484 India
PE Ratio
n/a
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 12.43B, an increase of 1,259.17%. That is a compound annual growth rate of 35.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 12.43B | 49.11% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 21.95B |
| Syncom Formulations (India) | 20.60B |
| Amrutanjan Health Care | 14.82B |
| TTK Healthcare | 14.59B |
| Fermenta Biotech | 13.99B |
| Kopran | 13.09B |
| Lincoln Pharmaceuticals | 10.95B |
| Sudarshan Pharma Industries | 9.26B |